{"title_page": "Isamoltane", "text_new": "{{Drugbox\n| IUPAC_name = 1-(propan-2-ylamino)-3-(2-pyrrol-1-ylphenoxy)propan-2-ol\n| image = Isamoltane.svg\n\n<!--Clinical data-->\n| tradename =  \n| pregnancy_category =  \n| routes_of_administration =\n\n<!--Pharmacokinetic data-->\n| bioavailability =  \n| metabolism =  \n| elimination_half-life =  \n| excretion =\n\n<!--Identifiers-->\n| CAS_number = 99740-06-4\n| UNII_Ref = {{fdacite|correct|FDA}}\n| UNII = 214SP5P1EX\n| ATC_prefix = none\n| ATC_suffix =  \n| PubChem = 127403\n| ChemSpiderID = 113051\n\n<!--Chemical data-->\n| C=16 | H=22 | N=2 | O=2 \n| molecular_weight = 274.357 g/mol\n| smiles = OC(CNC(C)C)COc1ccccc1n2cccc2\n}}\n\n'''Isamoltane''' ('''CGP-361A''') is a [[drug]] used in [[scientific research]]. It acts as an [[antagonist]] at the [[Beta-adrenergic receptor|\u03b2-adrenergic]], [[5-HT1A receptor|5-HT<sub>1A</sub>]], and [[5-HT1B receptor|5-HT<sub>1B</sub>]] [[receptor (biochemistry)|receptor]]s.<ref name=\"pmid8093601\">{{cite journal | vauthors = Langlois M, Br\u00e9mont B, Rousselle D, Gaudy F | title = Structural analysis by the comparative molecular field analysis method of the affinity of beta-adrenoreceptor blocking agents for 5-HT1A and 5-HT1B receptors | journal = Eur. J. Pharmacol. | volume = 244 | issue = 1 | pages = 77\u201387 | year = 1993 | pmid = 8093601 | doi = 10.1016/0922-4106(93)90061-d| url = }}</ref> It has about five times the potency for the 5-HT<sub>1B</sub> receptor (21 nmol/l) over the 5-HT<sub>1A</sub> receptor (112 nmol/l).<ref name=\"pmid1674359\">{{cite journal |vauthors=R\u00e9nyi L, Larsson LG, Berg S, Svensson BE, Thorell G, Ross SB | title = Biochemical and behavioural effects of isamoltane, a beta-adrenoceptor antagonist with affinity for the 5-HT1B receptor of rat brain. | journal = Naunyn Schmiedebergs Arch Pharmacol | volume = 343 | issue = 1 | pages = 1\u20136 | year = 1991 | pmid = 1674359 | doi=10.1007/bf00180669}}</ref> It has [[anxiolytic]] effects in rodents.<ref name=\"pmid2905765\">{{cite journal |vauthors=Waldmeier PC, Williams M, Baumann PA, Bischoff S, Sills MA, Neale RF | title = Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain. | journal = Naunyn Schmiedebergs Arch Pharmacol | volume = 337 | issue = 6 | pages = 609\u2013620 | year = 1988 | pmid = 2905765 | doi=10.1007/bf00175785}}</ref>\n\n==References==\n{{Reflist|2}}\n\n{{Anxiolytics}}\n{{Adrenergic receptor modulators}}\n{{Serotonin receptor modulators}}\n\n[[Category:5-HT1A antagonists]]\n[[Category:5-HT1B antagonists]]\n[[Category:Secondary alcohols]]\n[[Category:Beta blockers]]\n[[Category:Phenol ethers]]\n[[Category:Pyrroles]]\n[[Category:Isopropyl compounds]]\n[[Category:Amines]]\n", "text_old": "{{Drugbox\n| IUPAC_name = 1-(propan-2-ylamino)-3-(2-pyrrol-1-ylphenoxy)propan-2-ol\n| image = Isamoltane.svg\n\n<!--Clinical data-->\n| tradename =  \n| pregnancy_category =  \n| routes_of_administration =\n\n<!--Pharmacokinetic data-->\n| bioavailability =  \n| metabolism =  \n| elimination_half-life =  \n| excretion =\n\n<!--Identifiers-->\n| CAS_number = 99740-06-4\n| ATC_prefix = none\n| ATC_suffix =  \n| PubChem = 127403\n| ChemSpiderID = 113051\n\n<!--Chemical data-->\n| C=16 | H=22 | N=2 | O=2 \n| molecular_weight = 274.357 g/mol\n| smiles = OC(CNC(C)C)COc1ccccc1n2cccc2\n}}\n\n'''Isamoltane''' ('''CGP-361A''') is a [[drug]] used in [[scientific research]]. It acts as an [[antagonist]] at the [[Beta-adrenergic receptor|\u03b2-adrenergic]], [[5-HT1A receptor|5-HT<sub>1A</sub>]], and [[5-HT1B receptor|5-HT<sub>1B</sub>]] [[receptor (biochemistry)|receptor]]s.<ref name=\"pmid8093601\">{{cite journal | vauthors = Langlois M, Br\u00e9mont B, Rousselle D, Gaudy F | title = Structural analysis by the comparative molecular field analysis method of the affinity of beta-adrenoreceptor blocking agents for 5-HT1A and 5-HT1B receptors | journal = Eur. J. Pharmacol. | volume = 244 | issue = 1 | pages = 77\u201387 | year = 1993 | pmid = 8093601 | doi = 10.1016/0922-4106(93)90061-d| url = }}</ref> It has about five times the potency for the 5-HT<sub>1B</sub> receptor (21 nmol/l) over the 5-HT<sub>1A</sub> receptor (112 nmol/l).<ref name=\"pmid1674359\">{{cite journal |vauthors=R\u00e9nyi L, Larsson LG, Berg S, Svensson BE, Thorell G, Ross SB | title = Biochemical and behavioural effects of isamoltane, a beta-adrenoceptor antagonist with affinity for the 5-HT1B receptor of rat brain. | journal = Naunyn Schmiedebergs Arch Pharmacol | volume = 343 | issue = 1 | pages = 1\u20136 | year = 1991 | pmid = 1674359 | doi=10.1007/bf00180669}}</ref> It has [[anxiolytic]] effects in rodents.<ref name=\"pmid2905765\">{{cite journal |vauthors=Waldmeier PC, Williams M, Baumann PA, Bischoff S, Sills MA, Neale RF | title = Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain. | journal = Naunyn Schmiedebergs Arch Pharmacol | volume = 337 | issue = 6 | pages = 609\u2013620 | year = 1988 | pmid = 2905765 | doi=10.1007/bf00175785}}</ref>\n\n==References==\n{{Reflist|2}}\n\n{{Anxiolytics}}\n{{Adrenergic receptor modulators}}\n{{Serotonin receptor modulators}}\n\n[[Category:5-HT1A antagonists]]\n[[Category:5-HT1B antagonists]]\n[[Category:Secondary alcohols]]\n[[Category:Beta blockers]]\n[[Category:Phenol ethers]]\n[[Category:Pyrroles]]\n[[Category:Isopropyl compounds]]\n[[Category:Amines]]\n", "name_user": "Fswitzer4", "label": "safe", "comment": "added FDA UNII to drug box", "url_page": "//en.wikipedia.org/wiki/Isamoltane"}
